Related Experiment Videos
Retroviruses in radiation-induced lymphomas
Leukemia Research
|January 1, 1986
Summary
The radiation leukemia virus (RadLV/VL3) is a recombinant retrovirus. Its proviral DNA integration may confer a growth advantage to cells, not necessarily indicating viral induction of radiation-induced leukemogenesis.
Area of Science:
- Retroviral genetics
- Molecular virology
- Cancer research
Background:
- Radiation leukemia virus complex (RadLV/VL3) is a thymotropic and leukemogenic entity.
- RadLV/VL3(T+L+) is a recombinant retrovirus with genetic similarities to Akv MuLV and xenotropic MuLV.
Purpose of the Study:
- To analyze the nucleotide sequence of RadLV/VL3(T+L+).
- To investigate the role of enhancer elements in lymphomagenesis.
- To determine if proviral integration and clonal cell selection are indicative of viral induction of leukemogenesis.
Main Methods:
- Nucleotide sequencing of RadLV/VL3(T+L+).
- Analysis of proviral sequences adjacent to the c-myc gene in rat thymic lymphomas.
- In-vitro cell culture to assess growth advantage and clonal selection.
Main Results:
- RadLV/VL3(T+L+) exhibits a recombinant retroviral structure with features from Akv MuLV and xenotropic MuLV.
- Sequence rearrangements in the LTR suggest potential enhancer elements.
- Proviral integration at specific DNA sites can confer an in-vitro growth advantage and lead to clonal cell selection, independent of lymphomagenesis.
Conclusions:
- Clonal appearance of integrated provirus in cultured lymphoma cells does not necessarily imply viral induction of radiation-induced leukemogenesis.
- The observed growth advantage may be a non-specific phenomenon related to proviral integration site.